Paradigm Biopharmaceuticals Limited (PBIGF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 65.8 Thousand | 46.76 Thousand | 79.22 Thousand | 20.55 Thousand | - | 2.98 Million |
| Cost of Revenue | 8988.00 | 18.82 Thousand | 143.75 Thousand | 99.13 Thousand | 213.11 Thousand | 8348.00 |
| Gross Profit | 56.81 Thousand | 27.93 Thousand | -64.52 Thousand | -78.58 Thousand | -213.11 Thousand | 2.97 Million |
| Operating Expenses | 56.81 Thousand | 60.06 Million | 47.92 Million | 43.31 Million | 17.17 Million | 11.95 Million |
| Selling, General and Administrative Expenses | 6.21 Million | 6.56 Million | 7.93 Million | 8.74 Million | 4.16 Million | 4.04 Million |
| Research and Development Expenses | 58.33 Million | 52.67 Million | 39.01 Million | 33.51 Million | 12.79 Million | 7.89 Million |
| Other Expenses | - | 6.74 Million | 8.65 Million | 8.71 Million | 3.69 Million | 2.98 Million |
| Cost and Expenses | 65.11 Million | 60.08 Million | 48.06 Million | 43.41 Million | 17.17 Million | 11.95 Million |
| Operating Income | -65.11 Million | -51.89 Million | -39.22 Million | -34.25 Million | -12.26 Million | -5.02 Million |
| Interest Expense | 14.37 Thousand | 16.41 Thousand | 28.63 Thousand | 37.72 Thousand | 34.16 Thousand | - |
| Income Tax Expense | - | -7.04 Million | 8.68 Million | 8.74 Million | 3.73 Million | 6.65 Million |
| Earnings before Tax | -58.65 Million | -51.91 Million | -39.24 Million | -34.29 Million | -12.29 Million | -15.62 Million |
| Net Income | -58.65 Million | -51.91 Million | -39.24 Million | -34.29 Million | -12.29 Million | -15.62 Million |
| Earnings Per Share Basic | -0.20 | -0.18 | -0.16 | -0.16 | -0.06 | -0.11 |
| Earnings Per Share Diluted | -0.20 | -0.18 | -0.16 | -0.16 | -0.06 | -0.11 |
| Weighted Average Shares Outstanding | 293.28 Million | 289.67 Million | 240.96 Million | 212.19 Million | 208.26 Million | 148.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 293.28 Million | 289.67 Million | 241.81 Million | 212.19 Million | 208.26 Million | 148.13 Million |
| Gross Margin | 0.86 | 0.60 | -0.81 | -3.82 | - | 1.00 |
| EBIT Margin | -888.94 | -1109.79 | -494.29 | -1656.91 | - | -1.68 |
| Profit Margin | -891.39 | -1110.14 | -495.43 | -1668.96 | - | -5.24 |
| EBITDA | -58.49 Million | -51.89 Million | -39.15 Million | -34.04 Million | -16.88 Million | -5.01 Million |
| Earnings Before Tax Margin | -989.55 | -1109.79 | -495.06 | -1667.13 | - | -1.68 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 65.8 Thousand | 65.8 Thousand | - | - | - | 46.76 Thousand |
| Cost of Revenue | 155.72 Thousand | 4494.00 | 4494.00 | 73.39 Thousand | - | 18.82 Thousand |
| Gross Profit | -89.92 Thousand | 61.3 Thousand | -4494.00 | -73.39 Thousand | - | 27.93 Thousand |
| Operating Expenses | 64.4 Million | 7.47 Million | 7.47 Million | 49.82 Million | 24.58 Million | 60.06 Million |
| Selling, General and Administrative Expenses | - | 1.49 Million | 1.49 Million | 3.44 Million | 1.88 Million | - |
| Research and Development Expenses | - | 5.97 Million | 5.97 Million | 46.37 Million | 23.18 Million | - |
| Other Expenses | - | - | - | - | - | 6.74 Million |
| Cost and Expenses | 64.55 Million | 7.48 Million | 7.48 Million | 49.89 Million | 24.58 Million | 60.08 Million |
| Operating Income | -64.49 Million | -7.48 Million | -7.48 Million | -49.89 Million | -25.07 Million | -51.89 Million |
| Interest Expense | 14.37 Thousand | 7891.00 | - | 6479.00 | - | 16.41 Thousand |
| Income Tax Expense | -6.04 Million | -4.98 Million | - | -1.06 Million | - | -7.04 Million |
| Earnings before Tax | -64.7 Million | -4.84 Million | -4.84 Million | -50.01 Million | -24.47 Million | -51.91 Million |
| Net Income | -58.65 Million | -4.84 Million | -4.84 Million | -48.95 Million | -24.47 Million | -51.91 Million |
| Earnings Per Share Basic | - | -0.02 | -0.02 | -0.16 | -0.08 | - |
| Earnings Per Share Diluted | - | -0.02 | -0.02 | -0.16 | -0.08 | - |
| Weighted Average Shares Outstanding | 293.28 Million | 286.6 Million | 286.6 Million | 299.78 Million | 299.79 Million | 289.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 293.28 Million | 286.77 Million | 286.77 Million | 299.78 Million | 299.78 Million | 289.67 Million |
| Gross Margin | -1.37 | 0.93 | - | - | - | 0.60 |
| EBIT Margin | - | -113.16 | - | - | - | - |
| Profit Margin | -891.39 | -73.67 | - | - | - | -1110.14 |
| EBITDA | - | -7.44 Million | -7.44 Million | -49.82 Million | -25.03 Million | - |
| Earnings Before Tax Margin | -980.13 | -113.72 | - | - | - | -1109.79 |
603612
000560
3083
6605
1423
BINANIIND